Case Report: Rare pheochromocytoma in a patient with Li–Fraumeni syndrome: a 3-event, 4-hit model of pathogenesis

Li-Fraumeni syndrome (LFS) is a rare autosomal dominant hereditary cancer predisposition syndrome caused by germline <i>TP53</i> pathogenic variants. Despite numerous studies of associated cancers with this syndrome, cases of pheochromocytoma have not been well documented. We present a patient from an LFS family who developed a right adrenal mass with a clinical presentation consistent with a pheochromocytoma. Genetic studies of this tumor identified a germline <i>TP53</i> pathogenic variant (c.818G>A; p.Arg273His) with somatic loss of the wild-type allele (loss of heterozygosity, LOH). In addition, a likely somatic <i>NF1</i> pathogenic variant was found with concomitant LOH. There were no reported cases of pheochromocytoma in the family history. In addition, several bile duct adenomas (BDAs) were discovered and biopsied intraoperatively. Sequence analysis of one BDA revealed a likely somatic <i>FGFR2::FKR</i> pathogenic fusion and the identical germline <i>TP53</i> pathogenic variant. In contrast to the pheochromocytoma, the BDA showed no evidence of a second <i>TP53</i> alteration that might suggest that <i>TP53</i> had played a role in its pathogenesis. This case highlights the rare presentation of pheochromocytoma in LFS and provides a molecular hypothesis of how this tumor may have developed.

Authors

Institutions

Publication Details

Journal
Frontiers in Oncology
Published
2026-03-11
DOI
https://doi.org/10.3389/fonc.2026.1714565
Primary Topic
Cancer-related Molecular Pathways
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Case Report: Rare pheochromocytoma in a patient with Li–Fraumeni syndrome: a 3-event, 4-hit model of pathogenesis

Naris Nilubol, Payal P. Khincha, Aaron J Dinerman, Ashley Grossman et al.
Frontiers in Oncology
Cancer-related Molecular Pathways
article

Case Report: Rare pheochromocytoma in a patient with Li–Fraumeni syndrome: a 3-event, 4-hit model of pathogenesis

Naris Nilubol, Payal P. Khincha, Aaron J Dinerman, Ashley Grossman, Kathleen Calzone, Liqiang Xi, Karel Pacak, Mark Raffeld, Yi Liu, Kenneth Aldape, Ina Lee, Manoj Tyagi
article en

Abstract

Li-Fraumeni syndrome (LFS) is a rare autosomal dominant hereditary cancer predisposition syndrome caused by germline <i>TP53</i> pathogenic variants. Despite numerous studies of associated cancers with this syndrome, cases of pheochromocytoma have not been well documented. We present a patient from an LFS family who developed a right adrenal mass with a clinical presentation consistent with a pheochromocytoma. Genetic studies of this tumor identified a germline <i>TP53</i> pathogenic variant (c.818G>A; p.Arg273His) with somatic loss of the wild-type allele (loss of heterozygosity, LOH). In addition, a likely somatic <i>NF1</i> pathogenic variant was found with concomitant LOH. There were no reported cases of pheochromocytoma in the family history. In addition, several bile duct adenomas (BDAs) were discovered and biopsied intraoperatively. Sequence analysis of one BDA revealed a likely somatic <i>FGFR2::FKR</i> pathogenic fusion and the identical germline <i>TP53</i> pathogenic variant. In contrast to the pheochromocytoma, the BDA showed no evidence of a second <i>TP53</i> alteration that might suggest that <i>TP53</i> had played a role in its pathogenesis. This case highlights the rare presentation of pheochromocytoma in LFS and provides a molecular hypothesis of how this tumor may have developed.

Frontiers in OncologyVol. 16
National Institutes of Health (US), The Royal Free Hospital (GB), National Institute of Child Health (HU), National Cancer Institute (UA), National Cancer Institute (MY), Cancer Genetics (United States) (US), Center for Cancer Research (US), Health and Human Development (2HD) Research Network (CM), Department of Health and Human Services (US), University College London (GB)
National Institutes of Health, National Cancer Institute
Good health and well-being
Openalex Percentile: Top 26%
Cancer-related Molecular Pathways
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.